Cat. No. |
产品名称/活性 |
6313 |
A 33 |
| Potent and selective PDE4B inhibitor |
2237 |
BRL 50481 |
| Selective PDE7 inhibitor |
2793 |
Caffeine |
| Cyclic nucleotide PDE inhibitor |
0915 |
Cilostamide |
| PDE3 inhibitor |
0691 |
Dipyridamole |
| PDE5/6/8/10/11 inhibitor |
1261 |
EHNA hydrochloride |
| PDE2 inhibitor |
1693 |
Enoximone |
| PDE3 inhibitor |
5202 |
Furamidine dihydrochloride |
| TDP-1 inhibitor; PRMT1 inhibitor |
4165 |
Gisadenafil besylate |
| Potent PDE5 inhibitor; orally bioavailable |
2845 |
IBMX |
| PDE inhibitor (non-selective) |
1694 |
Ibudilast |
| PDE inhibitor (non-selective) |
3053 |
Mesopram |
| Orally active PDE4 inhibitor |
5915 |
PF 04449613 |
| Potent PDE9 inhibitor; brain penetrant |
6024 |
PF 04671536 hydrochloride |
| Potent and selective PDE8B/8A inhibitor |
6405 |
PF 05180999 |
| Potent and selective PDE2A inhibitor |
4525 |
Piclamilast |
| Potent and selective PDE4 inhibitor |
0415 |
Ro 20-1724 |
| PDE4 inhibitor |
0905 |
Rolipram |
| PDE4 inhibitor |
1349 |
(R)-(-)-Rolipram |
| PDE4 inhibitor. More active enantiomer of rolipram (Cat. No. 0905) |
3784 |
Sildenafil citrate |
| Potent PDE5 inhibitor; orally active |
6311 |
Tadalafil |
| Potent and highly selective PDE5 inhibitor; orally bioavailable |
2337 |
Trequinsin hydrochloride |
| Highly potent PDE3 inhibitor |
0947 |
Zaprinast |
| PDE5/6/9/11 inhibitor |